Sionna Therapeutics (SION) Preferred Shares Issued (2024)

Sionna Therapeutics' (SION) quarterly Preferred Shares Issued came in at $181.3 million in Q1 2024.

Sionna Therapeutics (SION) Preferred Shares Issued (2024) Analysis & Trends

Sionna Therapeutics has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $181.3 million for Q1 2024.

Preferred Shares Issued for Q1 2024 came in at $181.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $181.3 million (changed N/A YoY), and the FY2024 annual result was $181.3 million, changed N/A from the prior year.
Preferred Shares Issued came in at $181.3 million for Q1 2024 at Sionna Therapeutics.
In the past five years, Preferred Shares Issued ranged from a high of $181.3 million in Q1 2024 to a low of $181.3 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Sionna Therapeutics	1.61 Bn	1.61 Bn	-	-

Download Data

Date	Value
Mar 31, 2024	181.33 Mn
Mar 31, 2024	181.33 Mn